Skip to main content

Table 3 Univariable analysis of the impact of severity of illness on treatments administered

From: Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia

  Risk association Confidence interval P value
Beta interferon – 4.62 −8.40, −0.84 0.018
Alpha interferon – 1.24 −6.71, 4.24 0.652
Ribavirin 0.78 −3.34,4.90 0.704
Viral treatment – 5.98 −9.73, −2.23 0.002
Mycophenolate mofetil – 7.91 −12.90, −2.91 0.003
Hydrocortisone 3.03 −3.62,9.68 0.364